Nutromics receives FDA Breakthrough Device Designation

MELBOURNE, Australia & SAN DIEGO--(BUSINESS WIRE)--The FDA has granted Nutromics Breakthrough Device Designation for its first product in development - a wearable for vancomycin TDM.
Take Your Experience to the Next Level
NewDownload our mobile app for a faster and better experience.
Comments
0U
Join the discussion
Sign in to leave a comment